Raltegravir resistance in the cerebrospinal fluid

[1]  A. Winston,et al.  Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting. , 2012, The Journal of infection.

[2]  D. Fuchs,et al.  HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. , 2010, The Journal of infectious diseases.

[3]  S. Oka,et al.  Emergence of raltegravir-resistant HIV-1 in the central nervous system , 2010, International journal of STD & AIDS.

[4]  V. Calvez,et al.  HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis , 2010, AIDS (London).

[5]  R. Ellis,et al.  Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis , 2010, Journal of NeuroVirology.

[6]  R. Price,et al.  Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection , 2009, PloS one.

[7]  D. Hazuda,et al.  Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. , 2008, The New England journal of medicine.

[8]  C. Yiannoutsos,et al.  Antiretroviral Treatment Effect on Immune Activation Reduces Cerebrospinal Fluid HIV-1 Infection , 2008, Journal of acquired immune deficiency syndromes.

[9]  A. Aleixo,et al.  Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era , 2007, BMC infectious diseases.

[10]  C. Petropoulos,et al.  HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. , 2005, The Journal of infectious diseases.

[11]  M. Capobianchi,et al.  Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients , 2002, AIDS.

[12]  D. Cooper,et al.  Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid , 2000, AIDS.